BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 35500612)

  • 1. Antenatal intravenous immunoglobulins in pregnancies at risk of fetal and neonatal alloimmune thrombocytopenia: comparison of neonatal outcome in treated and nontreated pregnancies.
    Ernstsen SL; Ahlen MT; Johansen T; Bertelsen EL; Kjeldsen-Kragh J; Tiller H
    Am J Obstet Gynecol; 2022 Sep; 227(3):506.e1-506.e12. PubMed ID: 35500612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term neurodevelopmental outcome in children after antenatal intravenous immune globulin treatment in fetal and neonatal alloimmune thrombocytopenia.
    de Vos TW; de Haas M; Oepkes D; Tan RNGB; van der Schoot CE; Steggerda SJ; de Vries LS; Lopriore E; van Klink JMM
    Am J Obstet Gynecol; 2022 Oct; 227(4):637.e1-637.e9. PubMed ID: 35671780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Omission of fetal sampling in treatment of subsequent pregnancies in fetal-neonatal alloimmune thrombocytopenia.
    Lakkaraja M; Berkowitz RL; Vinograd CA; Manotas KC; Jin JC; Ferd P; Gabor J; Wissert M; McFarland JG; Bussel JB
    Am J Obstet Gynecol; 2016 Oct; 215(4):471.e1-9. PubMed ID: 27131591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antenatal noninvasive treatment of patients at risk for alloimmune thrombocytopenia without a history of intracranial hemorrhage.
    Yinon Y; Spira M; Solomon O; Weisz B; Chayen B; Schiff E; Lipitz S
    Am J Obstet Gynecol; 2006 Oct; 195(4):1153-7. PubMed ID: 17000248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neonatal alloimmune thrombocytopenia: antenatal management.
    Silver RM; Porter TF; Branch DW; Esplin MS; Scott JR
    Am J Obstet Gynecol; 2000 May; 182(5):1233-8. PubMed ID: 10819864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postnatal treatment for children with fetal and neonatal alloimmune thrombocytopenia: a multicentre, retrospective, cohort study.
    de Vos TW; Winkelhorst D; Árnadóttir V; van der Bom JG; Canals Surís C; Caram-Deelder C; Deschmann E; Haysom HE; Hverven HBC; Lozar Krivec J; McQuilten ZK; Muñiz-Diaz E; Nogués N; Oepkes D; Porcelijn L; van der Schoot CE; Saxonhouse M; Sola-Visner M; Tiblad E; Tiller H; Wood EM; Young V; Železnik M; de Haas M; Lopriore E
    Lancet Haematol; 2022 Nov; 9(11):e844-e853. PubMed ID: 36108655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-Dose versus Standard-Dose Intravenous Immunoglobulin to Prevent Fetal Intracranial Hemorrhage in Fetal and Neonatal Alloimmune Thrombocytopenia: A Randomized Trial.
    Paridaans NP; Kamphuis MM; Taune Wikman A; Tiblad E; Van den Akker ES; Lopriore E; Challis D; Westgren M; Oepkes D
    Fetal Diagn Ther; 2015; 38(2):147-53. PubMed ID: 25896635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-invasive risk-assessment and bleeding prophylaxis with IVIG in pregnant women with a history of fetal and neonatal alloimmune thrombocytopenia: management to minimize adverse events.
    Wienzek-Lischka S; Sawazki A; Ehrhardt H; Sachs UJ; Axt-Fliedner R; Bein G
    Arch Gynecol Obstet; 2020 Aug; 302(2):355-363. PubMed ID: 32495019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fetal and neonatal alloimmune thrombocytopenia: predictive factors of intracranial hemorrhage.
    Delbos F; Bertrand G; Croisille L; Ansart-Pirenne H; Bierling P; Kaplan C
    Transfusion; 2016 Jan; 56(1):59-66; quiz 58. PubMed ID: 26469867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New developments in fetal and neonatal alloimmune thrombocytopenia.
    Bussel JB; Vander Haar EL; Berkowitz RL
    Am J Obstet Gynecol; 2021 Aug; 225(2):120-127. PubMed ID: 33839095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review of the contemporary management of fetal and neonatal alloimmune thrombocytopenia in an Australian tertiary obstetric hospital.
    Cook TJ; Qiu CC; Dickinson JE
    Aust N Z J Obstet Gynaecol; 2012 Aug; 52(4):321-6. PubMed ID: 22510050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracranial hemorrhages in neonates born from 32 weeks of gestation-low frequency of associated fetal and neonatal alloimmune thrombocytopenia: a register-based study.
    Refsum E; Håkansson S; Mörtberg A; Wikman A; Westgren M
    Transfusion; 2018 Jan; 58(1):223-231. PubMed ID: 29119564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management and Neonatal Outcomes of Pregnancies with Fetal/Neonatal Alloimmune Thrombocytopenia: A Single-Center Retrospective Cohort Study.
    Ronzoni S; Keunen J; Shah PS; Kelly EN; Windrim R; Seaward PG; Ryan G
    Fetal Diagn Ther; 2019; 45(2):85-93. PubMed ID: 29669341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contemporary management of neonatal alloimmune thrombocytopenia: good outcomes in the intravenous immunoglobulin era: results from the Australian neonatal alloimmune thrombocytopenia registry.
    Crighton GL; Scarborough R; McQuilten ZK; Phillips LE; Savoia HF; Williams B; Holdsworth R; Henry A; Wood EM; Cole SA;
    J Matern Fetal Neonatal Med; 2017 Oct; 30(20):2488-2494. PubMed ID: 27806668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fetal and Neonatal Alloimmune Thrombocytopenia-New Prospects for Fetal Risk Assessment of HPA-1a-Negative Pregnant Women.
    Kjeldsen-Kragh J; Bengtsson J
    Transfus Med Rev; 2020 Oct; 34(4):270-276. PubMed ID: 33039264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fetal and neonatal alloimmune thrombocytopenia: recommendations for evidence-based practice, an international approach.
    Lieberman L; Greinacher A; Murphy MF; Bussel J; Bakchoul T; Corke S; Kjaer M; Kjeldsen-Kragh J; Bertrand G; Oepkes D; Baker JM; Hume H; Massey E; Kaplan C; Arnold DM; Baidya S; Ryan G; Savoia H; Landry D; Shehata N;
    Br J Haematol; 2019 May; 185(3):549-562. PubMed ID: 30828796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous immunoglobulins without initial and follow-up cordocentesis in alloimmune fetal and neonatal thrombocytopenia at high risk for intracranial hemorrhage.
    Kanhai HH; van den Akker ES; Walther FJ; Brand A
    Fetal Diagn Ther; 2006; 21(1):55-60. PubMed ID: 16354976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and laboratory predictors of fetal and neonatal alloimmune thrombocytopenia.
    Matusiak K; Patriquin CJ; Deniz S; Dzaja N; Smith JW; Wang G; Nazy I; Kelton JG; Arnold DM
    Transfusion; 2022 Nov; 62(11):2213-2222. PubMed ID: 36239096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prenatal Management of Pregnancies at Risk of Fetal Neonatal Alloimmune Thrombocytopenia (FNAIT): Scientific Impact Paper No. 61.
    Regan F; Lees CC; Jones B; Nicolaides KH; Wimalasundera RC; Mijovic A;
    BJOG; 2019 Sep; 126(10):e173-e185. PubMed ID: 30968555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of the fetal status in noninvasive management of alloimmune thrombocytopenia.
    Bertrand G; Drame M; Martageix C; Kaplan C
    Blood; 2011 Mar; 117(11):3209-13. PubMed ID: 21239703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.